Literature DB >> 7235683

Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents.

J B Woolcock, M D Mutimer.   

Abstract

The minimal concentrations of 26 antimicrobial agents required to inhibit growth of 100 isolates of Corynebacterium equi in vitro have been determined. The most active agents were penicillin G, doxycycline, erythromycin, lincomycin, and the aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7235683      PMCID: PMC353000          DOI: 10.1128/AAC.18.6.976

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Corynebacterium equi Magnusson isolated from a tuberculoid lesion in a child with adenitis colli.

Authors:  F Thomsen; R Henriques; M Magnusson
Journal:  Dan Med Bull       Date:  1968-05

2.  Lung abscess due to Corynebacterium equi in a renal transplant recipient.

Authors:  E Savdie; P Pigott; F Jennis
Journal:  Med J Aust       Date:  1977-05-28       Impact factor: 7.738

3.  Pneumonitis due to Corynebacterium equi.

Authors:  S E Gardner; T Pearson; W T Hughes
Journal:  Chest       Date:  1976-07       Impact factor: 9.410

  3 in total
  11 in total

1.  Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient.

Authors:  P Nordmann; E Rouveix; M Guenounou; M H Nicolas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

Review 2.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

3.  The lowly diphtheriod: nondiphtheria corynebacterial infections in humans.

Authors: 
Journal:  West J Med       Date:  1982-07

Review 4.  Osteomyelitis caused by Rhodococcus equi in a renal transplant recipient.

Authors:  R M Novak; E L Polisky; W M Janda; C R Libertin
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

5.  Spectrum of disease caused by Rhodococcus equi in human immunodeficiency virus infection: Report of a case and review of the literature.

Authors:  S K Willsie-Ediger; J F Stanford; G A Salzman; D M Bamberger
Journal:  Can J Infect Dis       Date:  1990

Review 6.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Penicillin-binding proteins of Rhodococcus equi: potential role in resistance to imipenem.

Authors:  P Nordmann; M H Nicolas; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

Review 8.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

9.  Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.

Authors:  M M McNeil; J M Brown
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Non-pulmonary Rhodococcus equi infections in patients with acquired immune deficiency syndrome (AIDS).

Authors:  J Fierer; P Wolf; L Seed; T Gay; K Noonan; P Haghighi
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.